Clinical Data Q2 Loss Rises Sharply on Acquisition Costs | GenomeWeb
NEW YORK (GenomeWeb News) – Clinical Data today posted a $70 million net loss for the second quarter, resulting primarily from charges related to its August acquisition of Adenosine Therapeutics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.